These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

719 related items for PubMed ID: 30113661

  • 21. The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis.
    Wang Y, Wang Y, Sun J.
    Bioengineered; 2022; 13(7-12):14960-14973. PubMed ID: 37105767
    [Abstract] [Full Text] [Related]

  • 22. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM, Mei L, Huang H, Cao SF, Zhao RH, Zheng PY.
    Zhonghua Gan Zang Bing Za Zhi; 2019 May 20; 27(5):369-375. PubMed ID: 31177662
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
    Lambert JE, Parnell JA, Eksteen B, Raman M, Bomhof MR, Rioux KP, Madsen KL, Reimer RA.
    BMC Gastroenterol; 2015 Dec 03; 15():169. PubMed ID: 26635079
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K, Chen J, Zhang T, Yuan X, Ge A, Wang S, Xu H, Zeng L, Ge J.
    Front Immunol; 2022 Dec 03; 13():949746. PubMed ID: 36159792
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta-analysis of clinical trials.
    Mansour-Ghanaei F, Hadi A, Pourmasoumi M, Joukar F, Golpour S, Najafgholizadeh A.
    Phytother Res; 2018 Oct 03; 32(10):1876-1884. PubMed ID: 29947156
    [Abstract] [Full Text] [Related]

  • 32. Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.
    Nigam P, Bhatt SP, Misra A, Vaidya M, Dasgupta J, Chadha DS.
    PLoS One; 2013 Oct 03; 8(1):e49286. PubMed ID: 23326306
    [Abstract] [Full Text] [Related]

  • 33. Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease.
    Tarantino G, Finelli C.
    Future Microbiol; 2015 Oct 03; 10(5):889-902. PubMed ID: 26000656
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tang G, Zhang L, Tao J, Wei Z.
    Phytother Res; 2021 Aug 03; 35(8):4183-4193. PubMed ID: 33728708
    [Abstract] [Full Text] [Related]

  • 36. Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    McFarlane C, Ramos CI, Johnson DW, Campbell KL.
    J Ren Nutr; 2019 May 03; 29(3):209-220. PubMed ID: 30366767
    [Abstract] [Full Text] [Related]

  • 37. The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Stachowska E, Portincasa P, Jamioł-Milc D, Maciejewska-Markiewicz D, Skonieczna-Żydecka K.
    Nutrients; 2020 Nov 11; 12(11):. PubMed ID: 33187278
    [Abstract] [Full Text] [Related]

  • 38. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
    Li XD, Qiu BH, Su FC, Sun SX.
    Clin Exp Hypertens; 2016 Nov 11; 38(7):639-643. PubMed ID: 27680771
    [Abstract] [Full Text] [Related]

  • 39. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease.
    Nabavi S, Rafraf M, Somi MH, Homayouni-Rad A, Asghari-Jafarabadi M.
    J Dairy Sci; 2014 Dec 11; 97(12):7386-93. PubMed ID: 25306266
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.